Peripheral Neuropathy Trial, Recruiting (NCT06216288)

Peripheral Neuropathy Trial, Recruiting NCT06216288 Sponsor: Cairo University Condition: Peripheral Neuropathy

Printed from Voxsanity (voxsanity.com.au) — NCT06216288 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Peripheral Neuropathy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have had ongoing, one-sided lower back and leg nerve pain (radiating from the lower spine) lasting more than 3 months
People between the ages of 35 and 60 years old
Both men and women are eligible
People who have a disc herniation or protrusion at the L4-L5 or L5-S1 level in the lower spine (where the disc has bulged or pushed outward to the back and side)
People who test positive on a "straight leg raise" test, which is a physical check where a doctor lifts the leg while the patient lies flat to see if it causes nerve pain

Who may not be able to join:

People who have previously had surgery on the lower spine or sacral area
People who have spinal canal narrowing (stenosis) or an abnormal sideways curve of the spine (scoliosis)
People who have a heart condition or cancer
People who have nerve damage in their arms or legs caused by conditions such as diabetes (peripheral neuropathy)
People who have an injury or condition affecting the brain or spinal cord that impacts movement and muscle control (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ahmed El Melhat, PhD, Cairo University

Phone: 01112595022

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06216288

Sponsor: Cairo University

Phase: Not Applicable

Status: Recruiting

Condition: Peripheral Neuropathy

Trial contact: 01112595022

More information: https://clinicaltrials.gov/study/NCT06216288

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have had ongoing, one-sided lower back and leg nerve pain (radiating from the lower spine) lasting more than 3 months
People between the ages of 35 and 60 years old
Both men and women are eligible
People who have a disc herniation or protrusion at the L4-L5 or L5-S1 level in the lower spine (where the disc has bulged or pushed outward to the back and side)
People who test positive on a "straight leg raise" test, which is a physical check where a doctor lifts the leg while the patient lies flat to see if it causes nerve pain

Who may not be able to join:

People who have previously had surgery on the lower spine or sacral area
People who have spinal canal narrowing (stenosis) or an abnormal sideways curve of the spine (scoliosis)
People who have a heart condition or cancer
People who have nerve damage in their arms or legs caused by conditions such as diabetes (peripheral neuropathy)
People who have an injury or condition affecting the brain or spinal cord that impacts movement and muscle control (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Cairo University

Registry

ClinicalTrials.gov

Start date

20 January 2024

Est. completion

1 September 2024

Where this trial is recruiting

🇪🇬 Egypt

Primary endpoints

Soleus H-reflex amplitude; Soleus H-reflex latency

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov